Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-27

Clinical Trial Update: A Study Investigating the Long-term Safety and Efficacy of Deferiprone in Patients With Friedreich's Ataxia [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 study evaluating the long-term safety and efficacy of deferiprone in patients with Friedreich's ataxia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Deferiprone (deferiprone)

Snippet

Sponsor: ApoPharma | Conditions: Friedreich's Ataxia | Phase 2 | Status: COMPLETED